Myelodysplastic Syndromes

Myelodysplastic syndromes are a group of blood disorders in which the bone marrow does not produce healthy, mature blood cells. Instead, the marrow makes abnormal or immature cells that fail to function properly. This leads to low levels of one or more types of blood cells, including red blood cells, white blood cells, and platelets.

Myelodysplastic syndromes mainly affect older adults and range from mild conditions that progress slowly to more severe forms that can evolve into acute leukemia. Early diagnosis and appropriate management can help control symptoms and slow disease progression.

Symptoms

Symptoms of myelodysplastic syndromes are related to low blood cell counts and may develop gradually over time.

Common symptoms include:

• Fatigue and weakness

• Shortness of breath

• Pale skin

• Frequent infections

• Fever

• Easy bruising

• Bleeding from gums or nose

• Small red or purple spots on the skin

• Dizziness

Some people may have no symptoms initially, and the condition is discovered during routine blood tests.

Causes

Myelodysplastic syndromes occur due to damage or mutations in the blood-forming stem cells of the bone marrow. These abnormal cells crowd out healthy cells and interfere with normal blood production.

Causes may include:

• Age-related changes in bone marrow

• Previous chemotherapy or radiation therapy

• Exposure to certain chemicals, such as benzene

• Genetic abnormalities in bone marrow cells

In many cases, the exact cause cannot be identified.

Risk Factors

Several factors can increase the risk of developing myelodysplastic syndromes.

Key risk factors include:

• Older age, especially over 60 years

• Prior cancer treatment with chemotherapy or radiation

• Long-term exposure to industrial chemicals

• Smoking

• Certain inherited bone marrow disorders

Men are slightly more likely than women to develop this condition.

Complications

Myelodysplastic syndromes can lead to serious complications if not properly managed.

Possible complications include:

• Severe anemia requiring frequent blood transfusions

• Recurrent or severe infections

• Excessive bleeding due to low platelet counts

• Iron overload from repeated transfusions

• Progression to acute myeloid leukemia

• Reduced quality of life

Regular monitoring is essential to detect complications early.

Prevention

There is no guaranteed way to prevent myelodysplastic syndromes, but some measures may help reduce risk or support early detection.

Preventive strategies include:

• Avoiding unnecessary exposure to toxic chemicals

• Using protective equipment in high-risk workplaces

• Limiting smoking

• Regular medical checkups, especially for individuals with known risk factors

• Ongoing follow-up after chemotherapy or radiation therapy

Early diagnosis and individualized treatment plans can significantly improve symptom control and long-term outcomes for people with myelodysplastic syndromes.